BOSTON (CBS) — A new study may change the way some breast cancers are treated.
WBZ NewsRadio 1030’s Diane Stern reports
[cbs-audio url=”http://www.podtrac.com/pts/redirect.mp3/nyc.podcast.play.it/media/d0/d0/d1/d4/dA/d0/dY/14A0Y_3.MP3″ size=”normal” download=”true” name=”Boston Doctor Part Of Study That Could Change Treatment For Some Breast Cancers” artist=”Diane Stern”]
Dr. Eric Winer, chief of the division of Women’s Cancers in the Susan F. Smith Center for Women’s Cancers at Dana-Farber,says researchers have discovered women with relatively small, HER2-positive breast tumors who received a combination of lower-intensity chemotherapy and a targeted therapy following surgery or radiation therapy, were very unlikely to have the cancer recur within a few years of treatment.
Winer is speaking about his breast cancer research at the San Antonio Breast Cancer Symposium, this week.
The findings offer, for the first time, a set of standard treatment guidelines for recurrence prevention in this group of patients.
“We tried to use a kind of gentler chemotherapy regime along…
View original post 161 more words